Discussion
Our data show persistent disparities in MLEA rates between the diabetes belt and surrounding areas. Over the 10-year study period, we consistently observed higher MLEA rates in the diabetes belt compared with the surrounding areas with rate ratios ranging from 1.37 to 1.56 over the study period (table 2). Both sets of counties exhibit large racial disparities in MLEA rates between white and black patients with larger disparities in the diabetes belt. Geographical differences may be attributed, in part, to a higher proportion of rural, black patients living in the diabetes belt than surrounding counties. This suggests racial minorities in the diabetes belt are doubly jeopardised for MLEA.
Our study was not designed to identify why black patients living the diabetes belt had higher rates of MLEA than their neighbouring counterparts. However, our findings linking rural residence, state Medicaid buy-in and limited care access to higher MLEA risks suggest an eroding healthcare infrastructure may be a factor.26 Over 80% of rural counties with majority Black populations are health professional shortage areas; most of these overlap with the diabetes belt.26 Furthermore, our group has shown that diabetes quality care metrics between the diabetes belt and surrounding counties are nearly equivalent after adjusting for provider shortages.27 When considering how efficient counties are in terms of providing diabetes preventive care, too few foot exams and eye exams were often identified as sources of inefficiencies.27 Although we did see a slowly narrowing gap in MLEA rates between regions and races over the horizon, there does not seem to be any clear evidence that this trend may have been affected by the ACA. A potential reason for this may be that expansion of federally qualified health centres had limited reach to rural patients, such as those that served in the diabetes belt.23
Our results are generally consistent with the declining trends in LEA rates in recent years that have amply been documented in the literature. Goldberg et al studied Medicare patients with diabetes over the period 1999–2006 and reported higher rates of amputation among Black patients.6 Margolis et al found a decreasing rate of incidence of LEA over 2006–2008 with higher rates clustered in some of the hospital referral regions in states overlapping with the diabetes belt, including Mississippi and Louisiana.28 29 Harding et al19 and Gregg et al30 presented amputation trends for patients 65 and older, with the general trend showing reduced rates of amputation during the early 2000s followed by flattening out or slight increase in amputation rates by around 2015. The findings of Harding et al19 are consistent with our work in that the rates for black patients are consistently higher than those for White patients. Our results go beyond what has previously been studied by providing rates for the diabetes belt specifically and highlighting the racial disparities in MLEA rates within the Belt and between the Belt and the surrounding counties.
Similar to the findings from Harding et al19 and Gregg et al,30 the rates among white patients in the diabetes belt and surrounding counties seem to be levelling off toward the end of the study period, potentially suggesting that we might have reached a floor for how low the MLEA rates can go under the current practice. Additional, targeted policies are needed to further reduce MLEA rates among disparity populations. Specifically, policies to prevent MLEAs among black patients in general and those in the diabetes belt are needed to eliminate the large racial disparities. Policies that specifically address patients in the diabetes belt should be prioritised given the disparity in MLEA rates between the diabetes belt and surrounding counties. These could include investing in healthcare infrastructure in rural counties with predominantly Black populations, which would potentially reduce both MLEA rates as well as disparities in premature death and other health outcomes.11 A policy specifically aimed at providing timely ambulatory care for Black patients, who are experiencing increasing difficulties accessing medical care independent of cost barriers,31 should be carefully considered.
Our results did not show any significant decreases in MLEAs after the ACA. While provisions of the ACA have reduced racial and rural disparities, further progress is needed.32 The CMS Office of Minority Health was one of six minority health offices established through the ACA to help highlight and address disparities. The geographical and racial MLEA disparities highlight a need for targeted interventions and strategies from the Office of Minority Health and other federal and local agencies to eliminate these disparities, particularly for the doubly disadvantaged black patients living in the diabetes belt.
As suggested by Eichner and Vladeck,20 Medicare can be a catalyst for reducing racial disparities in MLEA rates. CMS has several options to use for reducing disparities that include adjusting benefit and cost-sharing structures to reduce or eliminate out-of-pocket costs for low-income patients and implementing evidence-based guidelines for care to ensure all patients are treated with quality care despite physician bias. Further, CMS Quality Improvement Organisations can be used to engage patients at a community level to reduce disparities, an approach that would likely be helpful for reducing the regional and racial disparities we see in the diabetes belt.
Other research has highlighted potential approaches for reducing MLEA rates that may help reduce racial and geographical disparities. A pay-for-performance programme for diabetes providers that would provide incentives for reducing the rate of MLEAs may also have a significant impact on MLEA disparities.33 Multidisciplinary care teams including podiatrists, endocrinologists, wound care nurses and surgeons to manage diabetic foot ulcers have also become a recommended standard of care.34 These approaches are in line with Eichner and Vladeck’s suggestions for actions Medicare could take to address racial and ethnic health disparities, namely adjusting payment approaches and improving quality of care to reduce health disparities.
Limitations
Our work has limitations that need to be considered when interpreting our results. Some patient-level data were not available in the analysis, including behavioural factors such as smoking, physical activity, level of caregiving support for the patient and patient adherence to guideline recommendations such as daily foot checks, annual foot exams and A1c testing. These and other factors are relevant to the MLEA outcomes and may have confounded our results. We also were limited by the number of years of follow-up data we had available given that our most recent data are nearly a decade old. We plan to obtain additional years of follow-up to see whether these disparities continue to persist. The imputation of data at the zip code level using county-level data for the approximately 5% of patients who could not be linked to the zip code-level data is also a limitation.